Accessed:

(3α,5β,6β,8α,10α,13α,14β,16α,17α,24R)-16,25-Dihydroxy-3-(β-L-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl β-L-threo-hexopyranoside

19 of 21 defined stereocentres

Structural identifiers

Names and synonyms

[ACD/IUPAC Name]

(3α,5β,6β,8α,10α,13α,14β,16α,17α,24R)-16,25-Dihydroxy-3-(β-L-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl-β-L-threo-hexopyranosid

[German]

[ACD/IUPAC Name]

β-L-thréo-Hexopyranoside de (3α,5β,6β,8α,10α,13α,14β,16α,17α,24R)-16,25-dihydroxy-3-(β-L-xylopyranosyloxy)-20,24-époxy-9,19-cyclolanostan-6-yle

[French]

[ACD/IUPAC Name]

β-L-threo-Hexopyranoside, (3α,5β,6β,8α,10α,13α,14β,16α,17α,24R)-20,24-epoxy-16,25-dihydroxy-3-(β-L-xylopyranosyloxy)-9,19-cyclolanostan-6-yl

[ACD/Index Name]

83207-58-3

[RN]

Astragaloside A